Age-specific mortality and immunity patterns of SARS-CoV-2

@article{ODriscoll2020AgespecificMA,
  title={Age-specific mortality and immunity patterns of SARS-CoV-2},
  author={Megan O’Driscoll and Gabriel Ribeiro Dos Santos and Lin Wang and Derek A. T. Cummings and Andrew S. Azman and Juliette Paireau and Arnaud Fontanet and Simon Cauchemez and Henrik Salje},
  journal={Nature},
  year={2020},
  volume={590},
  pages={140-145}
}
Estimating the size of the coronavirus disease 2019 (COVID-19) pandemic and the infection severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is made challenging by inconsistencies in the available data. The number of deaths associated with COVID-19 is often used as a key indicator for the size of the epidemic, but the observed number of deaths represents only a minority of all infections 1 , 2 . In addition, the heterogeneous burdens in nursing homes and the variable… 

Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogens

Using 60-year-olds as a reference age group, it is found that relative rates of hospitalization and mortality associated with the emergent coronavirus are lower during childhood and start to increase earlier (around puberty) as compared with influenza and seasonal coronaviruses.

SARS-CoV-2 infections in 171 countries and over time

Age-stratified death count statistics, age-dependent infection fatality risks and stochastic modeling are used to estimate the prevalence and growth of SARS-CoV-2 infections among adults (age ≥ 20 years) in 171 countries, from early 2020 until April 9, 2021.

SARS-CoV-2 infections in 165 countries over time

  • S. Louca
  • Medicine
    International Journal of Infectious Diseases
  • 2021

Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies

The first estimates of the age-specific rates at which individuals infected with SARS-CoV-2 develop severe and critical disease are presented using multi-country serology studies, and public data on hospital admissions and mortality from early to mid-2020.

COVID-19 prevalence in 161 countries and over time

Age-stratified death count statistics, published age-dependent infection fatality risks and stochastic modeling are used to estimate the true prevalence and growth of COVID-19 infections among adults (age >=20 years) in 161 countries, from early 2020 until November 1, 2020.

Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany

A comparison of effective IFRs with observed CFRs indicates that a substantial fraction of the time-dependent variability in observed mortality can be explained by changes in the age distribution of infections.

Estimating the evolution of effective infection fatality rates during the course of the COVID-19 pandemic in Germany.

A comparison of estimated IFRs with observed CFRs indicates that a substantial fraction of the time-dependent variability in observed mortality can be explained by the evolving age distribution of infections.

High Level of SARS-CoV-2 Infection in Young Population Is a Predictor for Peak Incidence

In comparative analysis, the confirmed cases in young people (ages 20–29) increased prior to every outbreak peak and marked the tipping point in infection spread, indicating that a high level of SARS-CoV-2 infection in young population drives peak incidence and mortality across all age groups.

Immune response to COVID-19 in older adults

Comparing the age and sex trajectories of SARS-CoV-2 morbidity with other respiratory pathogens points to potential immune mechanisms.

Comparing age and sex differences in SARS-CoV-2 hospitalization and mortality with influenza and other health outcomes opens the way to generating hypotheses as to the underlying mechanisms, building
...

References

SHOWING 1-10 OF 42 REFERENCES

SARS-CoV-2 infection fatality risk in a nationwide seroepidemiological study

The authors' IFR estimates for SARS-CoV-2 are substantially greater than IFR estimators for seasonal influenza, justifying the implementation of special public health measures.

Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors.

  • C. ErikstrupC. Hother H. Ullum
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
The real-time nationwide anti-SARS-CoV-2 seroprevalence surveying of blood donations as a tool in monitoring the epidemic was initiated and the IFR was estimated to be slightly lower than previously reported from other countries not using serop revalence data.

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

An estimation of the clinical severity of COVID-19, based on the data available so far, can help to inform the public health response during the ongoing SARS-CoV-2 pandemic.

Estimating the burden of SARS-CoV-2 in France

France has been heavily affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and went into lockdown on 17 March 2020, and population immunity appears to be insufficient to avoid a second wave if all control measures are released at the end of the lockdown.

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

The results show that major non-pharmaceutical interventions and lockdown in particular have had a large effect on reducing transmission and continued intervention should be considered to keep transmission of SARS-CoV-2 under control.

Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.

Luxembourgish residents show a low rate of acute infections after 7 weeks of confinement and present with an antibody profile indicative of a more recent immune response to SARS-CoV-2.

Herd immunity is not a realistic exit strategy during a COVID-19 outbreak

This study provides vital information on the extent of virus spread in a country where social distancing is in place, concluding that herd immunity to SARS-CoV-2 is not a realistic short-term exit strategy option.

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.

Almost half of all school-aged children in Hong Kong were infected during the first wave of the pandemic H1N1 influenza A virus, and older adults aged 50-59 years had 9.5 and 66 times higher risks of ICU admission and death if infected, respectively.